"Our nano-vaccine offers a significant advantage over existing vaccines because it is needle-free and administered as a nasal spray," notes Prof. Satchi-Fainaro. "This eliminates the need for ...
“We synthesized them and encapsulated them into a nano-vaccine that is needle-free and administered as a nasal spray,” Satchi-Fainaro said. The nano-vaccine proved effective against all major ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...